BIMATOPROST/TIMOLOL ZENTIVA 0.3 mg/5 mg per ml, eye drop solution bottle, 3 ml
Active ingredients: Bimatoprost, Timolol maleate, TIMOLOL
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 3 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BIMATOPROST/TIMOLOL ZENTIVA 0,3 mg/5 mg par mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 3 ml avec compte-gouttes polyéthylène basse densité (PEBD)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jun 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63949960CIP73021699CIP133400930216996Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TIMOLOLcollyre | 6,8 mg · 1 mL de solution | SA |
| TIMOLOLcollyre | 5 mg · 1 mL de solution | FT |
| BIMATOPROSTcollyre | 0,3 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.